Translocations and deletions of the short arm of chromosome 12 [t(12p) and del(l2p)l are common recurring abnormalities in a broad spectrum of hematologic malignant diseases. We studied 20 patients and one cell line whose cells contained 1 2~1 3 translocations andlor 12p deletions using fluorescence in situ hybridization (FISH) with phage, plasmid, and cosmid probes that we previously mapped and ordered on 121312-13. FISH analysis showed that the 12~13 translocation breakpoints were clustered between t w o cosmids, 0128133 and D12S142, in 11 of 12 patients and in one cell line. FISH analysis of 11 patients with deletions demonstrated that the deletions were interstitial rather than terminal and that the distal part of 12~12, including the 601-04 gene and D12S54 marker, was deleted in all 11 patients. Moreover, FISH analysis showed that cells from 3 of these patients contained both a del(l2p) and a 1 2~1 3 translocation and that the affected regions of these rearrangements appeared t o overlap. We identified three yeast artificial chro-HE SHORT ARM OF chromosome 12 (12p) is one of the regions commonly involved in hematologic malignant diseases.' In addition to two recurring 1 2~1 3 translocations, ie, t(12; 13)(p13;q14)* and t(12; 17)(~13;q21)~ in acute lymphoblastic leukemia (ALL), a number of chromosomal bands, eg, 2pl1, 2ql1, 5q33, 7q32, 9pl1, 16q13, 1 7~1 1 , 20ql1, and 22q12, have been reported to be rearranged with 1 2~1 3 in various hematologic malignant diseases4
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Deletions of the short arm of chromosome 12 [del(l2p)] have been reported in approximately 5% of patients with childhood ALL.' Del(l2p) has also been noted in patients with acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), and myeloproliferative disease (MPD).4 Johansson et a15 recently reviewed more than 12,000 reported cases with hematologic diseases and found that del(l2p) is one of the most common deletions in ALL and AML. Recently, we showed that some leukemic cells thought to have a del( 12p) or unbalanced 12pll-l2 translocations on standard cytogenetic analysis actually represent 1 2~1 3 translocations with associated deletiom6 Whether one gene or a few genes are involved in these rearrangements is unknown.
We first constructed a cytogenetic map of 12p using twocolor fluorescence in situ hybridization (FISH) with 14 cosmid, phage, and plasmid probes that had been mapped to 12p previously either by single-color FISH or by genetic linkage analy~is."'~ We used these probes to study patients whose cells contained 1 2~1 3 translocations and have shown that the 1 2~1 3 translocation breakpoints were clustered between two cosmids, D12S133 and D12S142, in l l of 12 patients and in one cell line. We have identified three yeast artificial chromosome (YAC) clones that span all the 1 2~1 3 translocation breakpoints mapped between D 12s 133 and D12S 142. They have inserts of human DNA between 1.39 and 1.67 Mb.
In our analysis of 11 patients with 12p deletions, we identified a segment deleted in all patients studied. The smallest mosome (YAC) clones that span all the 1 2~1 3 translocation breakpoints mapped between D12S133 and D12S142. They have inserts of human DNA between 1.39 and 1.67 Mb. Because the region between D12S133 and D125142 also represents the telomeric border of the smallest commonly deleted region of 12p. we also studied patients with a del(l2p) using these YACs. The smallest YAC, 964~10, was deleted in 8 of 9 patients studied. In the other patient, the YAC labeled the del(l2p) chromosome more weakly than the normal chromosome 12, suggesting that a part of the YAC was deleted. Thus, most 1 2~1 3 translocation breakpoints were clustered within the sequences contained in the 1.39 Mb YAC and this YAC appears t o include the telomeric border of the smallest commonly deleted region. Whether the same gene is involved in both the translocations and deletions is presently unknown. 0 1994 by The American Society of Hematology.
YAC was deleted in 8 of 9 of those patients. Moreover, we identified 3 patients whose cells contain both a del( 12p) and a previously unidentified 12p translocation and have shown that both affected regions seem to overlap. We report here on the analysis of patients with these structural rearrangements.
MATERIALS AND METHODS

Patients.
Patients with hematologic malignant diseases and various 12p abnormalities studied at the University of Chicago were selected for FISH analysis. These patients included 9 patients and one cell line with cytogenetically identified 1 2~1 3 translocations. Between 1970 and 1993, we examined 32 patients whose cells contained a deletion of 12p. Cytogenetic material from I 1 of the 32 3474 KOBAYASHI ET AL Abbreviations: AUL, acute undifferentiated leukemia; t-AML, therapy-related AML; CML, chronic myelogenous leukemia; NHL, non-Hodgkin's lymphoma patients was available for FISH study. Three of these patients with deletions were found to have previously undetected 1 2~1 3 translocations. The clinical and cytogenetic data of these two groups of patients are summarized in Tables l and 2 . The clinical and cytogenetic data of patient 12 were also described elsewhere! Cytogenetic studies. Metaphase cells were prepared from bone marrow and/or peripheral blood cells or lymph node cells before treatment as described." The karyotypes were described according to the International System for Human Cytogenetic Nomenclature (ISCN 1991)."
Cell line. The SUP-B2 cell line was kindly provided by Dr S.D. Smith (University of Chicago, Chicago, IL).I3 The cell line was thought to have a t(2;4;12)(ql3;q25;pl3), but our FISH analysis using whole chromosome painting probes for chromosomes 2, 4, and 6 (WCP2 Spectrum Green, WCP4 Spectrum Orange, and WCP6 Spectrum Orange; Imagenetics, Naperville, IL) and a centromerespecific probe for chromosome 12 (CEPI2 Spectrum Orange; Imagenetics) showed that the cell line had a t(6; 12)(q23;p13) and an unbalanced 2;4 translocation.
In situ hybridization. The cosmid clones 9A12 (D1 2S235), 1 I AI (D12S237). 1E8A (D12S134), 12A9 (D12S199), 1G2B (D12S229). ID9 (D12S133), IC3 (D12S119), 1H9 (D12S142), and 1G5 (D12S140)'; phage clone LJH5 (D12S54)9; and plasmid clone CM-C2 (D12S20)' were described previously. Cosmid clone HTY3049cl Patients no. 4 , 11, and 12 are also included in Table 1 . Abbreviations: RAEB, refractory anemia with excess blasts; PVERA, polycythemia vera. * Revised karyotype after FISH analysis. t The karyotype of patient no. 12 was described elsewhere?
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observations) using sequence-tagged site-content mapping. The cosmid, phage, and plasmid probes were labeled with biotin-l l-dUTP andor digoxigenin-l I-dUTP using nick-translation. The YACs were separated from the yeast chromosomes with pulse field gel electrophoresis (PFGE); the YAC was excised from the gel and was amplified and labeled with biotin-l l-dUTP using sequence-independent amplificati~n.'~ Two-color FISH was performed as previously described. 16 Chromosomes and interphase cells were stained with 4 ' 6-diamidino-2-phenylindole dihydrochloride (DAPI).
To determine the order of DNA probes, the probes were initially hybridized to metaphase or prometaphase cells prepared from mitogen-stimulated lymphocytes. At least 15 cells and 25 chromosomes were analyzed for each combination of probes; the order observed in at least 70% of the cells was selected as the correct order." The slides were scored blindly without knowledge of the probes. To extend the level of resolution and to facilitate the ordering of probes that were too close to be resolved on metaphase chromosomes, probes were scored on interphase cells. Three probes were used for each hybridization; two of the probes were labeled with biotin and detected with fluorescein isothiocyanate (FITC), whereas the remaining probe was labeled with digoxigenin and was detected with rhodamine. A minimum of 50 to 100 separate nuclei were scored; the three-point order observed in at least 70% of the nuclei scored was selected as the correct order. The slides were scored blindly without knowledge of the probes.
In addition to the cosmid, phage, plasmid, and YAC probes, centromere-specific probes for chromosomes 12 and 14/22 (CEP12 Spectrum Orange [Imagenetics] and D14/2221 [Oncor, Gaithersburg, MD]), whole chromosome painting probes for chromosomes 2 and 9 (WCP2 and WCP9 Spectrum Orange; Imagenetics), and biotinylated whole chromosome painting probe for chromosome 14 (Oncor) were used to confirm our interpretation of complex rearrangements in patients' samples. On the average, 14 abnormal cells (range, 8 to 33) were scored per probe per patient.
RESULTS
Mapping of probes. By hybridizing the cosmid, phage, and plasmid probes to normal peripheral blood cells, we determined the order of the probes to be tel-(D12S235, D12S237, D12S134)-(D12S199, CCND2)-(D12S229, HTY3049~1-7)-D12S133-(D12S142, D12S119, GDI-D4)-(D12S54, D12S140, D12S20)-cen. We then used FISH analysis of interphase cells to determine the order of the probes that were close to each other. The final order is shown in Fig 1A and Table 3 .
FISH on patients with 1 2~1 3 translocations. FISH results are summarized in Table 3 and are illustrated in Fig 2. In 11 patients and the cell line (nos. 1 through 8, 10, and l l ) , probes D12S235 through D12S133 were translocated to the other chromosome, whereas probes D12S142 through D12S20 remained on the der(l2) chromosome (Fig 1B) . For patient no. 12, probes D12S235 through D12S133 were translocated, whereas the centromeric probes were deleted. A detailed description of the analysis of patients no. 4, 1 l, and 12 is provided in the section on deletions. In patient no. 9, probes D12S142 through D12S20 were inserted into 19q, whereas D12S235 through D12S133 stayed on the der(l2) chromosome. In summary, the 1 2~1 3 breaks were located between D12S133 and D12S142 in patients no. 1 through 12. In patient no. 13, the 1 2~1 3 translocation breakpoint was located just telomeric to D12S133.
In patients no. 1 through 10, YAC964c10 hybridized to both the der(l2) and the other rearranged chromosomes in addition to the normal chromosome 12, indicating that the YAC includes the translocation breakpoints in these patients. YAC958b8 was also split by all three translocations studied. In patient no. 13, YACs 9 6 4~1 0 and 912d5 hybridized only to the normal and rearranged chromosomes 12, indicating that the translocation breakpoint was telomeric to these YACs. Except for this patient (no. 13), YAC912d5 was also split by all the 1 2~1 3 translocations studied. Signals on the der(l2) chromosome [the der(l9) chromosome in patient no. 91 were much smaller than those on the other rearranged chromosome [the der( 12) chromosome in patient no. 91. As summarized in Table 3 , patient no. 9 has an insertion of 12p material into chromosome 19. These results suggest that YAC 912d5 is telomeric to YAC 9 6 4~1 0 and suggest that most of YAC912d5 is telomeric to the 1 2~1 3 translocation breakpoints (Fig 3) .
Delineation of 12p deletions by standard cytogenetic analysis. By cytogenetic analysis, 30 of 32 patients had interstitial deletions (Fig lB, lines a, b , and c). Nineteen patients had a large deletion, ie, a de1(12)(pllp13). Eleven patients had a smaller deletion, ie, a del( 12)(p12p13) in 8 or a de1(12)(pllp12) in 3. The other 2 patients were thought to have a terminal deletion, ie, de1(12)(p12) (Fig lB, line d) . Because cytogenetic material from these two patients was not available for FISH, we could not determine whether the deletions were terminal rather than interstitial. There was no correlation between the phenotype of the disease and the size of the 12p deletion determined cytogenetically. In summary, cytogenetic analysis suggested that band 1 2~1 2 was involved in all patients studied.
FISH analysis of deletion patients. Cells from 11 patients were available for FISH analysis. The results are summarized in Fig 1B and Table 4 and are illustrated in Fig 4. In each patient, we confirmed that loss of sequences on 12p had occurred. The deleted homologue in each patient retained the telomeric probes cosmid D12S235 through CCND2, confirming that the deletion was interstitial rather than terminal. The location of the distal breakpoint varied. The distal breakpoints were located between CCND2 and cosmid D12S229 in 1 patient (no. 14), between cosmids HTY3049cl-7 and D12S133 in 3 (nos. 15 through 17), and between cosmids D12S133 and D12S142 in 7 patients (nos. 4, 11, 12, and 18 through 21).
With the exception of patient no. 17, each patient was missing sequences detected by plasmid D12S20, the most centromeric marker used in this study; thus, a proximal flanking marker was not detected for any of the 11 patients, except for patient no. 17. In patient no. 17, the deleted homologue retained cosmid D12S140 and plasmid D12S20. By combining the results of the FISH analysis of the patients, we could determine the smallest commonly deleted segment. This region is flanked on the proximal side by D12S140 and on the distal side by D12S 133 and includes the markers D12S54, D12S142, and D12S119 and the GDI-D4 gene.
We had material available to analyze the status of the YAC probes in 9 of these 11 deletion patients. In patients no. 4 and 14 through 18, both YACs 912d5 and 9 6 4~1 0 were deleted (Table 4 ). In patients no. 19 and 20, YAC 964~10 was deleted, whereas YAC 912d5 labeled the del( 12) chromosome. However, signals on the del( 12) chromosome using YAC 912d5 were smaller than those on the normal chromosome 12, suggesting that this YAC was partially deleted. In patient no. 21, YAC 964~10 hybridized to the del( 12) chromosome, but the signals were smaller than those on the normal chromosome 12. In summary, YAC 964~10 was deleted in 8 of 9 patients with 12p deletions and it seemed to be partially deleted in 1 other patient (Fig 4) . Patients no. 11 and 12 who could not be studied with the YACs have the same distal breakpoint between D12S133 and D12S142 as do patients no. 4 and 19 through 21; therefore, it seems likely that YAC 964ClO would also be deleted in these 2 patients. Surprisingly, FISH also showed that the other homologue of chromosome 12 was involved in a previously unidentified translocation in 2 patients (nos. 4 and 1 1; Table 3 , Fig 4, and data not shown) . In patient no. 1 1 , FISH using biotinylated D14/2221 and digoxigenin-labeled cosmid D12S229 probes confirmed a 12; 22 translocation. FISH using WCP2 combined with D12S235 showed that chromosome 2 was the other involved chromosome in patient no. 12. Cells from patient no. 4 contained a complex chromosomal rearrangement involving chromosome 12. FISH using a biotinylated chromosome 14 painting probe combined with D12S229 or WCP9 confirmed that 12p was translocated to the der(l4) chromosome, previously thought to be a marker chromosome, and that part of chromosome 14 was translocated to the der(9) chromosome. FISH using the sequence from the PGDZ gene at 9q34.2-34.3 (kindly provided by Dr K. Stefansson, Harvard University, Boston, MA)" combined with CEP12 showed the translocation of material from 9q to 12p, thus confirming a t(9; 12; 14)(q34;~13;q22). Proximal probes D12S20 through D12S142 hybridized to the der(l2) chromosome in each patient, whereas distal probes D12S235 through D12S133 were translocated to the der(22) chromosome in patient no. 11 or to the der(l4) chromosome in patient no. 4. Thus, in these 3 patients, the 1 2~1 3 trans- location breakpoint was located between cosmids D12S133 and D12S142, which is the same as the majority of 1 2~1 3 breakpoints; moreover, the distal border of the smallest commonly deleted region is also the same.
DISCUSSION
We have shown that 12 of 13 1 2~1 3 translocation breakpoints are located between two cosmids, D12S133 and D12S142, using FISH analysis. We have also identified three YAC clones that contain the breakpoints between D12S133 and D12S142. Therefore, we have established that most 1 2~1 3 translocation breakpoints are clustered in less than 1.39 Mb, regardless of the partner chromosome or of the phenotype of disease.
Identification of YAC clones that span translocation breakpoints has been a critical step in cloning the genes involved in translocations when neither of the partner genes have been identified. For example, the MLL gene on 11q23I9 and MYHII gene on 16p13 involved in the inv(16)(p13q22)*' were cloned using YACs that were split in these chromosomal rearrangements. YACs 912d5 and 964~10 do not appear to be chimeric on FISH to normal peripheral blood cells or to include an interstitial deletion by FISH to an extended chromatin preparation (Kobayashi et al, unpublished results).
These YACs will also be useful in detecting unidentified translocations and showing complex rearrangements involving 12p13 on metaphase cells. The split hybridization signals produced by YACs 958b8 or 964~10 are so clear that they may be useful in detecting 1 2~1 3 translocations involving this region in interphase nuclei. However, YAC 912d5 may not be an appropriate clone for this purpose, because the signals on the der( 12) chromosome are so small that abnormal cells could be erroneously classified as normal ones using interphase cells. FISH to interphase nuclei with the appropriate YAC will enable us to detect minimal residual disease in remission or in post-bone marrow transplantation bone marrow from patients in whom the translocation has been detected at presentation. However, the sensitivity and specificity of interphase FISH remain to be determined.
Our cytogenetic analysis of the deletion patients suggested that 1 2~1 2 was missing in all of them. This finding is consistent with the results recently described by Johansson et al. 5 Moreover, by constructing a cytogenetic map of 12p and using this map to examine leukemic cells with a del(l2p), we have delineated the commonly deleted region. We have shown that the deletions are interstitial rather than terminal and that this region extends from 12~12.2 to 12~13.1, is flanked by cosmid D12S133 distally and by cosmid D12S140 proximally, and contains the GDZ-D4 gene and the D12S54, D12S119, and D12S142 markers. It is of interest that we have not yet identified any patients with homozygous deletions; this is different from deletions of 9p in which large homozygous deletions are relatively common in a wide variety of tumor types.*','' Although, at present, there are not sufficient data to estimate the physical size of this region, FISH analysis has clearly provided a more precise definition than cytogenetic analysis alone. We have also shown that YAC 964~10 was completely deleted in all but one of the
Examples of FISH analysis of leukemia cells with translocations of 12p. In (AI through (Cl, the normal chromosome 12 and de14121 chromosome are identified with an arrowhead and a large arrow, respectively. The other rearranged chromosome is identified with a short arrow. (A) illustrates the mapping of YAC 964~10 to a cell from patient no. 6; it hybridized t o the der(l2) and der1221 chromosome as well as to the normal chromosome 12. (B) illustrates mapping of YAC 912d5 t o a cell from patient no. 6; it hybridized t o the normal and rearranged chromosome 12 as well as t o the der1221 chromosome. Signals on the der(l2) are smaller than those on the other chromosomes. (C) illustrates the mapping of YAC 964~10 to a cell from patient no. 7; it hybridized t o the derll21 and der(l7) chromosome. (D) illustrates the mapping of YAC 964~10 to a cell from patient no. 4; it hybridized t o the der(l21 and der(l4) chromosome, identified with an arrowhead and arrow, respectively, but did not to the del(12) chromosome identified with a short arrow. In (E) and (F), the normal and del(12) chromosome are identified with an arrowhead and arrow, respectively. (E) illustrates the mapping of YAC964c10 t o a cell from patient no. 15; it hybridized only In (AI and (B) , the normal chromosome 12 and del(l2pl chromosome are identified with an arrowhead and arrow, respectively. (A) and (B1 illustrate the mapping of cosmids D12S134 and HTY3049cl-7, respectively, in a single cell from patient no. 14. D12S134 hybridized to the normal chromosome 12 and del(l2p) chromosome (Al. HTY3049cl-7 hybridized only to the normal chromosome 12 (B). (C) and (D) illustrate the mapping of cosmids D12Sll9 and D12S134, respectively, to the same cell from patient no. 4. The del(l2p) and "normal-looking" der(l2) chromosomes are identified with an arrowhead and arrow, respectively. The der(l4) chromosome is identified with a short arrow. D12S119 hybridized only t o the der(l2) (Cl. D12S134 hybridized to the del(l2pl and der(l4) chromosomes and not to the der(l2) chromosome (D).
12p deletions and that it seemed to be partially deleted in this case. This YAC is not chimeric using FISH and it is 1.39 mb in size.'' One of the important questions with regard to these I2p13 translocations and deletions is whether the same gene is we have described in this report. An analysis of TEL in these patients is presently ongoing.
If TEL is involved in these translocations, it would join MLL as a very 'promiscuous" gene.24,25 MLL has been identified as being involved in more than 25 different translocations or rearrangements.26 TEL joins an ever-enlarging family of ETS-related genes involved in chromosome translocations. TEL is one of the ETS family that has both a 5' helix-loop-helix (HLH) domain as well as a 3' DNA binding domain. The HLH domain is involved in proteinprotein interaction and it is essential for its transactivating function. The HLH domain does not bind DNA directly.*' Most of the translocations have been identified in sarcoma, eg, FLII and EGR in Ewing ~a r c o m a '~.~~; ERG has also been identified in the t(16;21) in AML.3' However, in the translocation involving TEL, the DNA-binding portion is replaced by sequences from PDGFRB. In contrast, in the translocations just cited, the DNA-binding segment is retained and the HLH domain is replaced by the partner gene. At present, we have no evidence to determine whether TEL is also the gene critical for the deletions. This question is the subject of current research.
We noted in Tables 1 and 2 that the deletions and translocations occur in patients whose malignant cells express lymphoid as well as myeloid markers and include both leukemia, myelodysplasia, and lymphoma. This feature is also true of translocations involving MLL.24,26 The assumption for MLL has been that it functions in a very early hematopoietic stem cell before lineage differentiation has occurred. No functional studies of the TEL protein have been described and, thus, its possible role in diverse diseases is unknown. Given the current progress in defining the location of the genes involved in the translocation and the identification of TEL as a likely candidate gene, the question of the number of genes involved in the translocations and deletions and their identity should emerge fairly rapidly.
